4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,400.00p
   
  • Change Today:
    -5.00p
  • 52 Week High: 1,435.00
  • 52 Week Low: 500.00
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 2,627
  • Market Cap: £179.27m

Regulatory News

4basebio Plc - Result of AGM 09-Jun-2022 11:39 PR Newswire
4basebio Plc - Director/PDMR Shareholding 12-May-2022 14:27 PR Newswire
4basebio Plc - Director/PDMR Shareholding 11-May-2022 11:57 PR Newswire
4basebio Plc - Final Result and Notice of AGM 09-May-2022 07:00 PR Newswire
Price Monitoring Extension 06-May-2022 14:00 RNS
4basebio Plc - Joint Development Agreement with ... 27-Apr-2022 07:00 PR Newswire
4basebio Plc - Rapidly Produced Customisable Syn... 23-Mar-2022 07:00 PR Newswire
Second Price Monitoring Extn 15-Mar-2022 16:41 RNS
Price Monitoring Extension 15-Mar-2022 16:35 RNS
Second Price Monitoring Extn 15-Mar-2022 14:05 RNS
Price Monitoring Extension 15-Mar-2022 14:01 RNS
Price Monitoring Extension 15-Mar-2022 11:00 RNS
Price Monitoring Extension 15-Mar-2022 09:00 RNS
Second Price Monitoring Extn 08-Mar-2022 09:05 RNS
Price Monitoring Extension 08-Mar-2022 09:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,400.00p
Change Today -5.00p
% Change -0.36 %
52 Week High 1,435.00
52 Week Low 500.00
Volume 2,627
Shares Issued 12.81m
Market Cap £179.27m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.15% below the market average72.15% below the market average72.15% below the market average72.15% below the market average72.15% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average
Price Trend
99.77% above the market average99.77% above the market average99.77% above the market average99.77% above the market average99.77% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
34.91% below the market average34.91% below the market average34.91% below the market average34.91% below the market average34.91% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average

4basebio Dividends

No dividends found

Trades for 31-May-2024

Time Volume / Share Price
15:35 1 @ 1,419.00p
15:08 141 @ 1,384.00p
12:16 715 @ 1,401.00p
12:17 1,000 @ 1,420.00p
11:32 354 @ 1,412.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page